Lesley Northrop

About Lesley Northrop

Executive Leader in Diagnostics | C-Suite P&L Oversight | Strategic Founder | Board-Ready GovernanceI am a visionary leader in the diagnostics and digital healthcare space, bringing over 20 years of experience in transforming scientific concepts into commercially successful products. Throughout my career, I have held senior executive roles across a diverse landscape—ranging from high-growth startups (Seed to Series F) to mid-cap public entities—consistently delivering exceptional results and driving market adoption. My leadership is defined by my ability to bridge the gap between clinical science and corporate finance. I have managed the full product ecosystem, including ideation, R&D, regulatory compliance, and business development. Credentials & Education:Scientific: BSc in Biochemistry; MSc & PhD in Neuroendocrinology; Fellow of the American Board of Medical Genetics and Genomics (ABMGG).Business: Columbia Business School Executive Education (Private Equity, Venture Capital, Financial Analysis, and Negotiation Strategies).Governance: Deep expertise in board governance, leveraged buyouts, and financial oversight, with active board and advisory experience.My executive track record demonstrates a mastery of both strategy and execution:Financial & P&L Growth: Drive company profitability by reducing divisional operational costs up to 50% and delivered a doubled gross margin by effective cost management and partnership revitalization. Fundraising & Valuation: Developed product innovation pipelines that secured double-digits ($M) in fundraising and boosted stock valuation. Product Innovation & Technology IP: Pioneered and commercialized high-throughput genomic diagnostics across multiple companies, leveraging ML/AI algorithms and multi-omics to drive disease risk prediction and deliver complete product development from concept to market. Operational Efficiency & Cost Control: I have a proven track record of delivering regulated diagnostic products in capital-constrained environments. I achieve this through relentless focus on operational efficiency and P&L discipline, by optimizing technology to significantly reduce COGS while maintaining budget.⌛Speed and Self-Sufficiency: I possess the unique ability to achieve rapid market entry for regulated diagnostics while minimizing capital expenditure. Driven the launch of several de novo diagnostic tests that advanced healthcare in complex areas (e.g, infertility, women\'s health, gynecological cancers).

Experience

1. Clinical Advisor

   Biotia

   Nov 2024 — Present · New York, NY, US

   Appointed as an advisor guiding the clinical, operational, and commercial strategy for a company leveraging sequencing and AI to create the world\'s leading microbial reference library and fight infectious diseases.

Education

• Boston University

  PhD, Neuroendocrinology, Reproduction & Genetics

  2002 — 2007

• Boston University

  Master, Science

  2002 — 2004

• State University of New York College at Potsdam

  Bachelor of Science, Biochemistry

  1992 — 1996

• Columbia University

  ABMGG Fellowship, Molecular Genetics and Cytogenetics

• Columbia Business School Executive Education

  Executive Business Certificate, Executive Education - Venture Capital and Private Equity Program